BiotechTube
Home/Jasper Therapeutics/Wen-Kai (Kevin) Weng
W(

Wen-Kai (Kevin) Weng

Chief Medical Officer

Jasper Therapeutics

Therapeutic Areas

HematologyOncologyRare Genetic DiseasesImmunology

Jasper Therapeutics Pipeline

DrugIndicationPhase
Briquilimab (JSP191)Conditioning for allogeneic hematopoietic cell transplant in Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS)Phase 1/2

Leadership Team at Jasper Therapeutics

RM
Ronald Martell
Executive Chairman of the Board
WD
William D. (Bill) Lis
Chief Executive Officer and Board Member
JM
Jeet Mahal
Chief Business Officer
AS
Anna S. Truppel-Hartmann
Senior Vice President, Clinical Development
SG
Sheila Gujrathi
Board Member
CL
Connie L. Matsui
Board Member
EG
Edgar G. Engleman
Board Member
K(
Katherine (Kathy) High
Scientific Advisory Board Member
MP
Mortimer Poncz
Scientific Advisory Board Member
AR
Andrew R. Rezvani
Scientific Advisory Board Member
View full Jasper Therapeutics profile